|
1
|
Stumvoll M, Goldstein BJ and van Haeften
TW: Type 2 diabetes: Principles of pathogenesis and therapy.
Lancet. 365:1333–1346. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Trayhurn P: Hypoxia and adipocyte
physiology: Implications for adipose tissue dysfunction in obesity.
Annu Rev Nutr. 34:207–236. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lysaght J, van der Stok EP, Allott EH,
Casey R, Donohoe CL, Howard JM, McGarrigle SA, Ravi N, Reynolds JV
and Pidgeon GP: Pro-inflammatory and tumour proliferative
properties of excess visceral adipose tissue. Cancer Lett.
312:62–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bai T, Li M, Liu Y, Qiao Z and Wang Z:
Inhibition of ferroptosis alleviates atherosclerosis through
attenuating lipid peroxidation and endothelial dysfunction in mouse
aortic endothelial cell. Free Radic Biol Med. 160:92–102. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sinha RA, Bruinstroop E, Singh BK and Yen
PM: Nonalcoholic fatty liver disease and hypercholesterolemia:
Roles of thyroid hormones, metabolites, and agonists. Thyroid.
29:1173–1191. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Santoleri D and Titchenell PM: Resolving
the paradox of hepatic insulin resistance. Cell Mol Gastroenterol
Hepatol. 7:447–456. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Laakso M and Kuusisto J: Insulin
resistance and hyperglycaemia in cardiovascular disease
development. Nat Rev Endocrinol. 10:293–302. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z
and Zhao Y: From pre-diabetes to diabetes: Diagnosis, treatments
and translational research. Medicina (Kaunas). 55:5462019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aase K, Lymboussaki A, Kaipainen A,
Olofsson B, Alitalo K and Eriksson U: Localization of VEGF-B in the
mouse embryo suggests a paracrine role of the growth factor in the
developing vasculature. Dev Dyn. 215:12–25. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hagberg CE, Mehlem A, Falkevall A, Muhl L,
Fam BC, Ortsäter H, Scotney P, Nyqvist D, Samén E, Lu L, et al:
Targeting VEGF-B as a novel treatment for insulin resistance and
type 2 diabetes. Nature. 490:426–430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Robciuc MR, Kivelä R, Williams IM, de Boer
JF, van Dijk TH, Elamaa H, Tigistu-Sahle F, Molotkov D, Leppänen
VM, Käkelä R, et al: VEGFB/VEGFR1-Induced expansion of adipose
vasculature counteracts obesity and related metabolic
complications. Cell Metab. 23:712–724. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hagberg CE, Falkevall A, Wang X, Larsson
E, Huusko J, Nilsson I, van Meeteren LA, Samen E, Lu L,
Vanwildemeersch M, et al: Vascular endothelial growth factor B
controls endothelial fatty acid uptake. Nature. 464:917–921. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wagenmakers AJM, Strauss JA, Shepherd SO,
Keske MA and Cocks M: Increased muscle blood supply and
transendothelial nutrient and insulin transport induced by food
intake and exercise: Effect of obesity and ageing. J Physiol.
594:2207–2222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Falkevall A, Mehlem A, Palombo I, Heller
Sahlgren B, Ebarasi L, He L, Ytterberg AJ, Olauson H, Axelsson J,
Sundelin B, et al: Reducing VEGF-B signaling ameliorates renal
lipotoxicity and protects against diabetic kidney disease. Cell
Metab. 25:713–726. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moessinger C, Nilsson I, Muhl L,
Zeitelhofer M, Heller Sahlgren B, Skogsberg J and Eriksson U:
VEGF-B signaling impairs endothelial glucose transcytosis by
decreasing membrane cholesterol content. EMBO Rep. 21:e493432020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jensen N, Ning FC, Mi J, Lindström W,
Balan M, Muhl L, Eriksson U, Nilsson I and Nyqvist D: VEGF-B
ablation in pancreatic β-cells upregulates insulin expression
without affecting glucose homeostasis or islet lipid uptake. Sci
Rep. 10:9232020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shibuya M: VEGF-VEGFR system as a target
for suppressing inflammation and other diseases. Endocr Metab
Immune Disord Drug Targets. 15:135–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zachary I and Gliki G: Signaling
transduction mechanisms mediating biological actions of the
vascular endothelial growth factor family. Cardiovasc Res.
49:568–581. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen Z, Zhang Z, Wang X and Yang K:
VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy
through Ca2+-mediated PKG I pathway. J Cell Biochem.
119:1511–1520. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu L, Shan Z, Wang F, Gao X and Tong Y:
Vascular endothelial growth factor B exerts lipid-lowering effect
by activating AMPK via VEGFR1. Life Sci. 276:1194012021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Claesson-Welsh L: VEGF receptor signal
transduction-A brief update. Vascul Pharmacol. 86:14–17. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bates DO: Vascular endothelial growth
factors and vascular permeability. Cardiovasc Res. 87:262–271.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Osawa T, Muramatsu M, Wang F, Tsuchida R,
Kodama T, Minami T and Shibuya M: Increased expression of histone
demethylase JHDM1D under nutrient starvation suppresses tumor
growth via down-regulating angiogenesis. Proc Natl Acad Sci USA.
108:20725–20729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mehlem A, Palombo I, Wang X, Hagberg CE,
Eriksson U and Falkevall A: PGC-1α coordinates mitochondrial
respiratory capacity and muscular fatty acid uptake via regulation
of VEGF-B. Diabetes. 65:861–873. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu J, Wei H, Qu H, Feng Z, Long J, Ge Q
and Deng H: Plasma vascular endothelial growth factor B levels are
increased in patients with newly diagnosed type 2 diabetes mellitus
and associated with the first phase of glucose-stimulated insulin
secretion function of β-cell. J Endocrinol Invest. 40:1219–1226.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kivelä R, Bry M, Robciuc MR, Räsänen M,
Taavitsainen M, Silvola JM, Saraste A, Hulmi JJ, Anisimov A,
Mäyränpää MI, et al: VEGF-B-induced vascular growth leads to
metabolic reprogramming and ischemia resistance in the heart. EMBO
Mol Med. 6:307–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Samuel VT, Petersen KF and Shulman GI:
Lipid-induced insulin resistance: Unravelling the mechanism.
Lancet. 375:2267–2277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Louzier V, Raffestin B, Leroux A,
Branellec D, Caillaud JM, Levame M, Eddahibi S and Adnot S: Role of
VEGF-B in the lung during development of chronic hypoxic pulmonary
hypertension. Am J Physiol Lung Cell Mol Physiol. 284:L926–L937.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reichelt M, Shi S, Hayes M, Kay G, Batch
J, Gole GA and Browning J: Vascular endothelial growth factor-B and
retinal vascular development in the mouse. Clin Exp Ophthalmol.
31:61–65. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun CY, Lee CC, Hsieh MF, Chen CH and Chou
KM: Clinical association of circulating VEGF-B levels with
hyperlipidemia and target organ damage in type 2 diabetic patients.
J Biol Regul Homeost Agents. 28:225–236. 2014.PubMed/NCBI
|
|
33
|
Shen Y, Chen W, Han L, Bian Q, Fan J, Cao
Z, Jin X, Ding T, Xian Z, Guo Z, et al: VEGF-B antibody and
interleukin-22 fusion protein ameliorates diabetic nephropathy
through inhibiting lipid accumulation and inflammatory responses.
Acta Pharm Sin B. 11:127–142. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng F, Zhao L, Wu Y, Huang T, Yang G,
Zhang Z, Wu Y, Jia F, Wu J, Chen C and Liu D: Serum vascular
endothelial growth factor B is elevated in women with polycystic
ovary syndrome and can be decreased with metformin treatment. Clin
Endocrinol (Oxf). 84:386–393. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Abdul Razak MK and Sultan AA: The
importance of measurement of plasma fibrinogen level among patients
with type-2 diabetes mellitus. Diabetes Metab Syndr. 13:1151–1158.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lam DW and LeRoith D: The worldwide
diabetes epidemic. Curr Opin Endocrinol Diabetes Obes. 19:93–96.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Clayton EL, Evans GJ and Cousin MA: Bulk
synaptic vesicle endocytosis is rapidly triggered during strong
stimulation. J Neurosci. 28:6627–6632. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao A, Ohara-Imaizumi M, Brissova M,
Benninger RK, Xu Y, Hao Y, Abramowitz J, Boulay G, Powers AC,
Piston D, et al: Gαo represses insulin secretion by reducing
vesicular docking in pancreatic beta-cells. Diabetes. 59:2522–2529.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pan JY, Yuan S, Yu T, Su CL, Liu XL, He J
and Li H: Regulation of L-type Ca2+ channel activity and
insulin secretion by huntingtin-associated protein 1. J Biol Chem.
291:26352–26363. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wollam J, Mahata S, Riopel M,
Hernandez-Carretero A, Biswas A, Bandyopadhyay GK, Chi NW, Eiden
LE, Mahapatra NR, Corti A, et al: Chromogranin A regulates vesicle
storage and mitochondrial dynamics to influence insulin secretion.
Cell Tissue Res. 368:487–501. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vakilian M, Tahamtani Y and Ghaedi K: A
review on insulin trafficking and exocytosis. Gene. 706:52–61.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nash AD, Baca M, Wright C and Scotney PD:
The biology of vascular endothelial growth factor-B (VEGF-B). Pulm
Pharmacol Ther. 19:61–69. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gilbert M, Jung SR, Reed BJ and Sweet IR:
Islet oxygen consumption and insulin secretion tightly coupled to
calcium derived from L-type calcium channels but not from the
endoplasmic reticulum. J Biol Chem. 283:24334–24342. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gauthier BR and Wollheim CB:
Synaptotagmins bind calcium to release insulin. Am J Physiol
Endocrinol Metab. 295:E1279–E1286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shang R, Lal N, Lee CS, Zhai Y, Puri K,
Seira O, Boushel RC, Sultan I, Räsänen M, Alitalo K, et al:
Cardiac-specific VEGFB overexpression reduces lipoprotein lipase
activity and improves insulin action in rat heart. Am J Physiol
Endocrinol Metab. 321:E753–E765. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Anisimov A, Leppänen VM, Tvorogov D,
Zarkada G, Jeltsch M, Holopainen T, Kaijalainen S and Alitalo K:
The basis for the distinct biological activities of vascular
endothelial growth factor receptor-1 ligands. Sci Signal.
6:ra522013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bry M, Kivelä R, Leppänen VM and Alitalo
K: Vascular endothelial growth factor-B in physiology and disease.
Physiol Rev. 94:779–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rafii S and Carmeliet P: VEGF-B improves
metabolic health through vascular pruning of fat. Cell Metab.
23:571–573. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Feng S, Bowden N, Fragiadaki M, Souilhol
C, Hsiao S, Mahmoud M, Allen S, Pirri D, Ayllon BT, Akhtar S, et
al: Mechanical activation of hypoxia-inducible factor 1α drives
endothelial dysfunction at atheroprone sites. Arterioscler Thromb
Vasc Biol. 37:2087–2101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu D, Lei L, Desir M, Huang Y, Cleman J,
Jiang W, Fernandez-Hernando C, Di Lorenzo A, Sessa WC and Giordano
FJ: Smooth muscle hypoxia-inducible factor 1α links intravascular
pressure and atherosclerosis-brief report. Arterioscler Thromb Vasc
Biol. 36:442–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ghorbanzadeh V, Mohammadi M, Dariushnejad
H, Chodari L and Mohaddes G: Effects of crocin and voluntary
exercise, alone or combined, on heart VEGF-A and HOMA-IR of HFD/STZ
induced type 2 diabetic rats. J Endocrinol Invest. 39:1179–1186.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jin H, Li D, Wang X, Jia J, Chen Y, Yao Y,
Zhao C, Lu X, Zhang S, Togo J, et al: VEGF and VEGFB play balancing
roles in adipose differentiation, gene expression, and function.
Endocrinology. 159:2036–2049. 2018. View Article : Google Scholar : PubMed/NCBI
|
